Skip to Content
End of Year Sale. Save up to thirty five percent off sitewide.End of Year Sale. Save up to thirty five percent off sitewide.
2024 Black Friday Sale. Save up to forty percent off Books, eBooks, Journals, and select Personal Digital Subscription products.2024 Black Friday Sale. Save up to forty percent off Books, eBooks, Journals, and select Personal Digital Subscription products.

Lung Cancer, An Issue of Hematology/Oncology Clinics, 1st Edition

Authors :
Roy S. Herbst & Daniel Morgensztern
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemothera ...view more
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!
Add to Cart
This issue of Hematology/Oncology Clinics will focus on lung cancer; specifically, Genomics in lung cancer; Neoadjuvant and adjuvant therapy for NSCLC; Treatment of locally advanced NSCLC; First line systemic therapy for NSCLC; Second line chemotherapy and beyond for NSCLC; Treatment of EGFR mutant tumors; Treatment of ALK positive tumors; New targets in NSCLC; Immunotherapy; Advances in Small cell lung cancer; and many more!

Author Information
By Roy S. Herbst, MD, PhD, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine and Daniel Morgensztern, MD, Washington University School of Medicine